<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="./PMC3266527/results/search/disease/results.xml">
  <result pre="treatment of the most common types of headaches and for" exact="trigeminal neuralgia" post="in Denmark. The guideline was published in Danish in"/>
  <result pre="guidelines. The recommendations regarding the most common primary headaches and" exact="trigeminal neuralgia" post="are largely in accordance with the European guidelines produced"/>
  <result pre="and treatment of each of the major headache disorders and" exact="trigeminal neuralgia." post="The guideline includes many tables to facilitate a quick"/>
  <result pre="normal Danish general practice, more than 10% of patients have" exact="migraine" post="and more than 5% suffer from a chronic, often"/>
  <result pre="an increasing trend and the recent introduction of novel specific" exact="migraine" post="medications and novel prophylactic pharmaceuticals contributes to a considerable"/>
  <result pre="rare headache conditions. International general recommendations on the treatment of" exact="migraine" post="and other primary headache disorders are now in place,"/>
  <result pre="such guidelines in the Danish context. In Denmark, patients with" exact="trigeminal neuralgia" post="and other types of facial pain are typically treated"/>
  <result pre="in Denmark such as migraine, tension-type headache, cluster headache and" exact="trigeminal neuralgia" post="and to describe the &quot;warning signs&quot; of serious life-threatening"/>
  <result pre="including motor symptoms); newly presenting headache in an HIV or" exact="cancer" post="patient; headache/facial pain accompanied by fever or neurological symptoms;"/>
  <result pre="will produce physical findings including lacrimation, reddening of the eyes," exact="ptosis" post="and similar symptoms (see Sect. 5). In trigeminal neuralgia,"/>
  <result pre="the eyes, ptosis and similar symptoms (see Sect. 5). In" exact="trigeminal neuralgia," post="pain trigger points can often be identified (see Sect."/>
  <result pre="without aura Diagnosis The two most frequently occurring types of" exact="migraine" post="are migraine with aura and migraine without aura. Many"/>
  <result pre="Diagnosis The two most frequently occurring types of migraine are" exact="migraine" post="with aura and migraine without aura. Many patients have"/>
  <result pre="frequently occurring types of migraine are migraine with aura and" exact="migraine" post="without aura. Many patients have both types. Migraine without"/>
  <result pre="phono- and photophobia (see Table 3). Table 3 Classification of" exact="migraine" post="without aura and typical aura with migraine headache ["/>
  <result pre="3 Classification of migraine without aura and typical aura with" exact="migraine" post="headache [ 1] 1.1 [G43.0/N89] Migraine without aura A."/>
  <result pre="Not attributed to another disorder 1.2.1 [G43.10/N89] Typical aura with" exact="migraine" post="headache A. At least two attacks fulfilling criteria B–D"/>
  <result pre="therefore be useful to focus on the overall differences between" exact="migraine" post="and the most frequent differential diagnosis, tension-type headache, when"/>
  <result pre="important to keep in mind that many patients suffer from" exact="migraine" post="as well as tension-type headache. Table 4 summarises the"/>
  <result pre="two types of headache. Table 4 Characteristics to distinguish between" exact="migraine" post="and tension-type headache Migraine Tension-type headache Time pattern Attacks"/>
  <result pre="a mild nausea, photophobia or phonophobia Approximately, a third of" exact="migraine" post="patients have migraine with aura [ 2]. The aura"/>
  <result pre="photophobia or phonophobia Approximately, a third of migraine patients have" exact="migraine" post="with aura [ 2]. The aura phase consists of"/>
  <result pre="symptoms from the vision and tactile senses, such as flickering" exact="scotoma" post="and sensory disturbances. Transitory aphasia also occurs. Typically, symptoms"/>
  <result pre="tactile senses, such as flickering scotoma and sensory disturbances. Transitory" exact="aphasia" post="also occurs. Typically, symptoms develop gradually over minutes, every"/>
  <result pre="motor weakness, the condition is classified as hemiplegic migraine. In" exact="migraine" post="with aura, the headache phase frequently meets the criteria"/>
  <result pre="with aura, the headache phase frequently meets the criteria for" exact="migraine" post="without aura and is then classified as typical aura"/>
  <result pre="without aura and is then classified as typical aura with" exact="migraine" post="headache (see Table 3). It should be noted that"/>
  <result pre="that such headache does not necessarily meet the criteria for" exact="migraine" post="without aura. In these cases, the migraine is diagnosed"/>
  <result pre="the criteria for migraine without aura. In these cases, the" exact="migraine" post="is diagnosed as typical aura with non-migraine headache or"/>
  <result pre="men have migraine. This is a particularly pronounced trend in" exact="migraine" post="without aura, where the M/ F ratio is 1:3"/>
  <result pre="understanding of the mechanisms behind migraine. It is probable that" exact="migraine" post="is a neurovascular disease in which a genetic disposition"/>
  <result pre="to reach the correct diagnosis, particularly to distinguish between mild" exact="migraine" post="attacks and tension-type headache, and to exclude medication overuse"/>
  <result pre="to exclude medication overuse headache. Comorbidity, e.g. hypertension, asthma, severe" exact="obesity" post="and depression, shall also be diagnosed and managed. Comorbid"/>
  <result pre="medication. Migraine is a benign condition, but women who have" exact="migraine" post="with aura are at increased risk of stroke, even"/>
  <result pre="factors have a positive effect: information about the causes of" exact="migraine" post="and about treatment options; a thorough examination allowing the"/>
  <result pre="may be beneficial. Biofeedback therapy has a documented effect on" exact="migraine" post="[ 8]. Behavioural therapy and cognitive therapy (stress and"/>
  <result pre="has been demonstrated that the following have an effect on" exact="migraine" post="attacks: paracetamol, acetylsalicylic acid and various NSAIDs [ 2,"/>
  <result pre="10]. See Table 5 for recommended doses. Table 5 Acute" exact="migraine" post="treatment, first step: simple analgesics and antiemetics with demonstrated"/>
  <result pre="first step: simple analgesics and antiemetics with demonstrated effect in" exact="migraine" post="attack treatment using the recommended initial doses [ 2,"/>
  <result pre="6 presents the triptans marketed in Denmark. Table 6 Acute" exact="migraine" post="treatment, second step: triptans available in Denmark (stated by"/>
  <result pre="is essential that the patient is able to distinguish between" exact="migraine" post="and tension-type headache. Some studies seem to indicate that"/>
  <result pre="spray, suppository or subcutaneous injection). Approximately, 20–50% of patients experience" exact="migraine" post="relapse within 48 h. An additional dose of triptan"/>
  <result pre="is generally considered successful if the frequency or intensity of" exact="migraine" post="is halved without introducing bothersome side effects [ 10]."/>
  <result pre="summarise the first-, second- and third-line drugs. Table 7 Prophylactic" exact="migraine" post="medication first-line medication [ 10] Medicinal product Daily dose"/>
  <result pre="canal blocker Flunarizine 5–10 mg Recommended doses Table 8 Prophylactic" exact="migraine" post="medication, second- and third-line medications [ 10] and recommended"/>
  <result pre="also be used in short periods for treatment of menstrual" exact="migraine" post="[ 21] (see the section on migraine and hormones)."/>
  <result pre="treatment of menstrual migraine [ 21] (see the section on" exact="migraine" post="and hormones). Candesartan has few side effects [ 22]."/>
  <result pre="moderate intensity. Such headache is not associated with the typical" exact="migraine" post="characteristics such as aggravation by physical activity, vomiting or"/>
  <result pre="correct diagnosis, particularly to distinguish between tension-type headache and mild" exact="migraine" post="attacks and to exclude medication overuse headache. Physical examination"/>
  <result pre="4. Ipsilateral forehead and facial perspiration 5. Ipsilateral miosis and/or" exact="ptosis" post="6. A sense of restlessness or agitation D. Attacks"/>
  <result pre="occurring secondary headache caused by overuse of analgesics and/or acute" exact="migraine" post="medications [ 1]. MOH is primarily seen as a"/>
  <result pre="developing over weeks to months, particularly with either an increased" exact="migraine" post="frequency, awakening headache or characteristic shifts even within a"/>
  <result pre="headache or characteristic shifts even within a single day from" exact="migraine" post="to tension-type headache. The majority of prophylactic measures, pharmacological"/>
  <result pre="analgesics are taken for other indications, e.g. back pain or" exact="arthritis" post="conditions [ 48]. Background MOH occurs in 1–2% of"/>
  <result pre="in association with all analgesics including opioids and more specific" exact="migraine" post="drugs such as triptans [ 47, 48, 50, 51]."/>
  <result pre="is very homogeneous across studies: 65–70% of the patients had" exact="migraine" post="as their primary diagnosis, 27–30% tension-type headache and 8–20%"/>
  <result pre="differential diagnoses to MOH are primarily chronic tension-type headache and" exact="migraine" post="and combinations hereof. Naturally, other secondary headache causes should"/>
  <result pre="primary treatment elements: Abrupt discontinuation of all analgesics and acute" exact="migraine" post="medicine or a reduction of the intake of attack"/>
  <result pre="2 months have passed, a restrictive intake of analgesics or" exact="migraine" post="medications is again acceptable. Ongoing registration of medication intake"/>
  <result pre="secondary headache condition caused by overuse of analgesics and acute" exact="migraine" post="medication. The treatment course may be protracted and difficult"/>
  <result pre="headache induced or maintained by overuse of analgesics or specific" exact="migraine" post="medication [ 56, 57]. The prognosis is generally good,"/>
  <result pre="including motor symptoms); newly presenting headache in an HIV or" exact="cancer" post="patient; headache/facial pain accompanied by fever or neurological symptoms;"/>
  <result pre="on clinical suspicion before any biopsy results are available. Primary" exact="glaucoma" post="Headache may be a symptom in narrow-angle glaucoma; rarely"/>
  <result pre="predisposition, female sex and myopia; the condition may present as" exact="ocular hypertension;" post="painful red eye; semi-dilated pupil with no reaction to"/>
  <result pre="cases [ 64]; fluctuating neurological symptoms: paresis (60%), papilloedema (30–60%)," exact="meningitis" post="(25–30%), reduced level of consciousness (60%), epileptic seizures (40–50%)."/>
  <result pre="the carotid, vertebral or basilar artery; severe arterial hypertension and" exact="hypertensive encephalopathy;" post="neuroinfection or severe systemic infection (including sinusitis); Arnold Chiari"/>
  <result pre="the diagnosis. Trigeminal neuralgia Diagnosis In the majority of cases," exact="trigeminal neuralgia" post="(TN) is a unilateral condition with ultra-short stabbing pain"/>
  <result pre="often a more constant, diffuse pain. Table 18 Characteristics of" exact="trigeminal neuralgia" post="In the majority of cases, trigeminal neuralgia is a"/>
  <result pre="18 Characteristics of trigeminal neuralgia In the majority of cases," exact="trigeminal neuralgia" post="is a unilateral condition with ultra-short stabbing pain located"/>
  <result pre="for weeks to months, and in rare cases, years Symptomatic" exact="trigeminal neuralgia" post="may, e.g. be caused by space-occupying processes of the"/>
  <result pre="caused by space-occupying processes of the fossa posterior and by" exact="multiple sclerosis." post="If the cause is pressure from vessels of the"/>
  <result pre="cerebellopontine angle, the case is diagnosed as classical and non-symptomatic" exact="trigeminal neuralgia" post="Table 19 Diagnostic criteria of trigeminal neuralgia 13.1 [G50.00/N92]"/>
  <result pre="classical and non-symptomatic trigeminal neuralgia Table 19 Diagnostic criteria of" exact="trigeminal neuralgia" post="13.1 [G50.00/N92] Classic trigeminal neuralgia A. Paroxysmal attacks of"/>
  <result pre="Table 19 Diagnostic criteria of trigeminal neuralgia 13.1 [G50.00/N92] Classic" exact="trigeminal neuralgia" post="A. Paroxysmal attacks of pain lasting from a fraction"/>
  <result pre="short-circuiting of the nerve fibres). TN is furthermore seen in" exact="multiple sclerosis" post="and in idiopathic cases [ 65]. Clinical assessment A"/>
  <result pre="any neurovascular contact and to exclude any secondary cause (e.g." exact="multiple sclerosis," post="tumours). Non-pharmacological treatment A limited number of patients report"/>
  <result pre="standard analgesics and opioids is usually very limited. In severe" exact="trigeminal neuralgia" post="where acute intervention is needed, infusion of phenytoin or"/>
  <result pre="with the guidelines of classic TN. Table 20 Treatment of" exact="trigeminal neuralgia" post="Primarily prophylactic pharmacological treatment with anti-epileptics Normally, weak analgesics"/>
  <result pre="a higher recurrence rate. Summary In the majority of cases," exact="trigeminal neuralgia" post="is a unilateral condition with ultra-short stabbing pain located"/>
  <result pre="microvascular decompression or lesion treatment should be considered. Hormones and" exact="migraine" post="This section describes the particular conditions associated with migraine"/>
  <result pre="and migraine This section describes the particular conditions associated with" exact="migraine" post="in relation to menstruation, hormonal treatment, pregnancy and breast-feeding."/>
  <result pre="relation to menstruation, hormonal treatment, pregnancy and breast-feeding. Diagnosis Menstrual" exact="migraine" post="is defined as migraine attacks occurring on the first"/>
  <result pre="treatment, pregnancy and breast-feeding. Diagnosis Menstrual migraine is defined as" exact="migraine" post="attacks occurring on the first menstrual day ± 2"/>
  <result pre="cyclic hormone therapy. The overwhelming majority of women also have" exact="migraine" post="attacks at points in time that are unrelated to"/>
  <result pre="that are unrelated to their menstrual cycle. In such cases," exact="migraine" post="is classified as menstrually related migraine. If attacks occur"/>
  <result pre="is defined as pure menstrual migraine. Background The occurrence of" exact="migraine" post="is associated with the menstrual cycle. This is particularly"/>
  <result pre="associated with the menstrual cycle. This is particularly pronounced for" exact="migraine" post="without aura [ 67]. Migraine is equally frequent in"/>
  <result pre="but approximately three times as many women as men have" exact="migraine" post="after puberty. Migraine may be triggered by a sudden"/>
  <result pre="remained high for several days [ 68]. This explains why" exact="migraine" post="occurs more frequently at menstrual periods and less frequently"/>
  <result pre="ovulation. Around menopause, some women experience an aggravation of their" exact="migraine" post="[ 69]. After menopause, both the incidence [ 70]"/>
  <result pre="the incidence [ 70] and the prevalence [ 71] of" exact="migraine" post="decrease. Specific risk factors The risk of cerebral infarction"/>
  <result pre="71] of migraine decrease. Specific risk factors The risk of" exact="cerebral infarction" post="is approximately doubled in women with migraine with aura"/>
  <result pre="risk of cerebral infarction is approximately doubled in women with" exact="migraine" post="with aura compared with the background population. If these"/>
  <result pre="take oestrogen-containing contraceptive pills, the risk is considerably higher. As" exact="cerebral infarction" post="occurs rarely in young persons, it is difficult to"/>
  <result pre="is now considered a fact that young women who have" exact="migraine" post="with aura are at an increased risk of cerebral"/>
  <result pre="have migraine with aura are at an increased risk of" exact="cerebral infarction." post="It is important to put this into perspective, as"/>
  <result pre="to put this into perspective, as the absolute risk of" exact="cerebral infarction" post="remains small in young women with migraine (18 cases"/>
  <result pre="risk of cerebral infarction remains small in young women with" exact="migraine" post="(18 cases per 100,000 female years). In one study,"/>
  <result pre="overweight of cardiovascular risk factors was found in patients with" exact="migraine" post="[ 73], but the causes of the increased risk"/>
  <result pre="[ 73], but the causes of the increased risk of" exact="cerebral infarction" post="in women with migraine with aura remain unknown. Women"/>
  <result pre="of the increased risk of cerebral infarction in women with" exact="migraine" post="with aura remain unknown. Women above 45 years of"/>
  <result pre="aura remain unknown. Women above 45 years of age with" exact="migraine" post="without aura do not have an increased risk of"/>
  <result pre="migraine without aura do not have an increased risk of" exact="cerebral infarction" post="[ 74]. Migraine with aura is thus a risk"/>
  <result pre="74]. Migraine with aura is thus a risk factor for" exact="cerebral infarction" post="in women, and the risk is more pronounced in"/>
  <result pre="take oestrogen-containing contraceptive pills [ 75]. In women suffering from" exact="migraine" post="with aura it is essential, to the extent possible,"/>
  <result pre="possible, to reduce other known and modifiable risk factors for" exact="cardiovascular disease" post="(hypertension, hypercholesterolaemia, smoking, etc.) [ 76]. Contraceptive measures without"/>
  <result pre="contraceptives only containing progesterone do not increase the risk of" exact="cerebral infarction" post="[ 78]. Young women who have migraine with aura"/>
  <result pre="risk of cerebral infarction [ 78]. Young women who have" exact="migraine" post="with aura are strongly encouraged not to smoke. Women"/>
  <result pre="aura are strongly encouraged not to smoke. Women who have" exact="migraine" post="with aura should be informed that they have a"/>
  <result pre="contraceptive pills. Consequently, for the overwhelming majority of these patients," exact="migraine" post="is a benign if bothersome condition with a good"/>
  <result pre="with a good prognosis. The effect of hormone treatments on" exact="migraine" post="There are no well-executed prospective studies which show how"/>
  <result pre="no well-executed prospective studies which show how contraceptive pills affect" exact="migraine" post="occurrence. Two retrospective studies reported that 24–35% of women"/>
  <result pre="occurrence. Two retrospective studies reported that 24–35% of women with" exact="migraine" post="experienced an aggravation, 5% an improvement and 44–65% no"/>
  <result pre="aggravation, 5% an improvement and 44–65% no change in their" exact="migraine" post="during treatment with contraceptive pills [ 79]. In a"/>
  <result pre="a recent, population-based study from Norway, an increased occurrence of" exact="migraine" post="was found among women taking oestrogen-containing contraceptive pills ["/>
  <result pre="as in the majority of cases this does not aggravate" exact="migraine" post="in contrast to oral hormone treatment [ 68]. Surgical"/>
  <result pre="bilateral oophorectomy can generally not be recommended as these aggravate" exact="migraine" post="in most cases [ 81]. Treatment of menstrual migraine"/>
  <result pre="aggravate migraine in most cases [ 81]. Treatment of menstrual" exact="migraine" post="The principles of non-pharmacological treatment and attack treatment in"/>
  <result pre="The principles of non-pharmacological treatment and attack treatment in menstrual" exact="migraine" post="do not differ from those of non-hormone associated migraine."/>
  <result pre="migraine, however, tends to be more difficult to treat than" exact="migraine" post="which is not associated with menstruation [ 80]. Prophylactic"/>
  <result pre="with menstruation [ 80]. Prophylactic treatment of menstrual migraine. Menstrual" exact="migraine" post="may be treated by not stopping the use of"/>
  <result pre="Pregnancy The patient is advised to be patient, as the" exact="migraine" post="will end or recede considerably during pregnancy in 70%"/>
  <result pre="in 70% of patients. In the overwhelming majority of cases," exact="migraine" post="recurs after birth or at the end of the"/>
  <result pre="contraindicated due to its uterus-contracting effect. Prophylactic treatment Note that" exact="migraine" post="will often improve during pregnancy. Prophylactic treatment should be"/>
  <result pre="E. Not attributed to another disorder e 1.3.2 [G43.820/N89] Abdominal" exact="migraine" post="A. At least five attacks fulfilling criteria B–D B."/>
  <result pre="always necessary to exclude any other condition. Differential diagnoses: intermittent" exact="bowel obstruction" post="(malrotation); kidney, liver or pancreas disease; increased intracranial pressure;"/>
  <result pre="or pancreas disease; increased intracranial pressure; poisoning; metabolic disease and" exact="epilepsy" post="fMedical history, and physical and neurological examinations should not"/>
  <result pre="occur in some attacks Background Migraine in children differs from" exact="migraine" post="in adults, particularly due to the following: shorter duration"/>
  <result pre="syndromes which occur in children (cyclic tendency to vomit, abdominal" exact="migraine" post="or benign paroxysmal vertigo) may be precursors to adult"/>
  <result pre="headache in children The acute and prophylactic medical treatment of" exact="migraine" post="and tension-type headache are different Treatment of acute attack"/>
  <result pre="attack of tension-type headache (paracetamol and/or NSAID) Treatment of acute" exact="migraine" post="attack (paracetamol, and/or NSAID combined with domperidone; alternatively sumatriptan"/>
  <result pre="underpin the effectiveness of prophylactic medical treatment in children with" exact="migraine" post="and tension-type headache is very limited Prophylactic pharmacological treatment"/>
  <result pre="months to ensure that daily medication is still necessary Acute" exact="migraine" post="treatment There is a documented effect of treatment with"/>
  <result pre="Rasmussen BK Jorgensen T Jensen R Has the prevalence of" exact="migraine" post="and tension-type headache changed over a 12-year period? A"/>
  <result pre="N Sanchez del RM Wu O et al. Mechanisms of" exact="migraine" post="aura revealed by functional MRI in human visual cortex"/>
  <result pre="and topography of cerebral blood flow, aura, and headache during" exact="migraine" post="attacks Ann Neurol 1990 28 791 798 10.1002/ana.410280610 2285266"/>
  <result pre="R Ashina M Tfelt-Hansen P Origin of pain (nociception) in" exact="migraine" post="Lancet Neurol 2009 8 7 679 690 10.1016/S1474-4422(09)70090-0 19539239"/>
  <result pre="oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for" exact="migraine" post="Lancet 1995 346 923 926 10.1016/S0140-6736(95)91554-0 7564725 10. Evers"/>
  <result pre="No effect of eletriptan administration during the aura phase of" exact="migraine" post="Eur J Neurol 2004 11 671 677 10.1111/j.1468-1331.2004.00914.x 15469451"/>
  <result pre="an adjunct to analgesics for the outpatient treatment of acute" exact="migraine" post="Ann Pharmacother 2008 42 397 402 10.1345/aph.1K481 18285561 13."/>
  <result pre="Goadsby PJ Oral triptans (serotonin 5-HT (1B/1D) agonists) in acute" exact="migraine" post="treatment: a meta-analysis of 53 trials Lancet 2001 358"/>
  <result pre="Schellenberg R Moeckesch B Banik N Early treatment of a" exact="migraine" post="attack while pain is still mild increases the efficacy"/>
  <result pre="WJ Sumatriptan and naproxen sodium for the acute treatment of" exact="migraine" post="Headache 2005 45 983 991 10.1111/j.1526-4610.2005.05178.x 16109111 16. Schulman"/>
  <result pre="Diener HC Pfeil J Schwalen S Topiramate 100 mg/day in" exact="migraine" post="prevention: a pooled analysis of double-blind randomised controlled trials"/>
  <result pre="al. A randomized trial of divalproex sodium extended-release tablets in" exact="migraine" post="prophylaxis Neurology 2002 58 1652 1659 12058094 20. Sorensen"/>
  <result pre="Larsen BH Rasmussen MJ et al. Flunarizine versus metoprolol in" exact="migraine" post="prophylaxis: a double-blind, randomized parallel group study of efficacy"/>
  <result pre="10.1111/j.1526-4610.1991.hed3110650.x 1769820 21. Welch KM Ellis DJ Keenan PA Successful" exact="migraine" post="prophylaxis with naproxen sodium Neurology 1985 35 1304 1310"/>
  <result pre="LJ Helde G Sand T Bovim G Prophylactic treatment of" exact="migraine" post="with an angiotensin II receptor blocker: a randomized controlled"/>
  <result pre="Secular changes in health care utilization and work absence for" exact="migraine" post="and tension-type headache: a population based study Eur J"/>
  <result pre="New appendix criteria open for a broader concept of chronic" exact="migraine" post="Cephalalgia 2006 26 742 746 10.1111/j.1468-2982.2006.01172.x 16686915 46. Ashina"/>
  <result pre="DC Booth CM Does this patient with headache have a" exact="migraine" post="or need neuroimaging? JAMA 2006 296 1274 1283 10.1001/jama.296.10.1274"/>
  <result pre="Brennum J Gjerris F Jensen R What is new about" exact="idiopathic intracranial hypertension?" post="An updated review of mechanism and treatment Cephalalgia 2006"/>
  <result pre="G Gronseth G Alksne J et al. AAN-EFNS guidelines on" exact="trigeminal neuralgia" post="management Eur J Neurol 2008 15 1013 1028 10.1111/j.1468-1331.2008.02185.x"/>
  <result pre="et al. Practice parameter: the diagnostic evaluation and treatment of" exact="trigeminal neuralgia" post="(an evidence-based review): report of the Quality Standards Subcommittee"/>
  <result pre="Frith A Ellis J Aspinall L Hackshaw A Incidence of" exact="migraine" post="relative to menstrual cycle phases of rising and falling"/>
  <result pre="HC Kurth T Dodick D Patent foramen ovale, stroke, and" exact="cardiovascular disease" post="in migraine Curr Opin Neurol 2007 20 310 319"/>
  <result pre="Dodick D Patent foramen ovale, stroke, and cardiovascular disease in" exact="migraine" post="Curr Opin Neurol 2007 20 310 319 10.1097/WCO.0b013e328136c22d 17495626"/>
  <result pre="Logroscino G Diener HC Buring JE Migraine and risk of" exact="cardiovascular disease" post="in women JAMA 2006 19 296 283 291 10.1001/jama.296.3.283"/>
  <result pre="Loder E Migraine with aura and increased risk of ischaemic" exact="stroke" post="BMJ 2009 339 b4380 10.1136/bmj.b4380 19861379 78. Ashkenazi A"/>
  <result pre="Lay CL Broner SW Special considerations in the treatment of" exact="migraine" post="in women Semin Neurol 2006 26 217 222 10.1055/s-2006-939922"/>
  <result pre="AP Berger MY Passchier J Koes BW Symptomatic treatment of" exact="migraine" post="in children: a systematic review of medication trials Pediatrics"/>
  <result pre="S Rahmann A Kraemer C et al. Treatment of childhood" exact="migraine" post="attacks with oral zolmitriptan and ibuprofen Neurology 2006 67"/>
  <result pre="H Hoppu K Nasal sumatriptan is effective in treatment of" exact="migraine" post="attacks in children: a randomized trial Neurology 2004 62"/>
  <result pre="D Yonker M Silberstein S Practice parameter: pharmacological treatment of" exact="migraine" post="headache in children and adolescents: report of the American"/>
  <result pre="15623677 87. Victor S, Ryan SW (2003) Drugs for preventing" exact="migraine" post="headaches in children. Cochrane Database Syst Rev CD002761 88."/>
  <result pre="AP Berger MY Passchier J Koes BW Prophylactic treatment of" exact="migraine" post="in children. Part 2. A systematic review of pharmacological"/>
 </snippets>
</snippetsTree>
